S

Shandong Weigao Blood Purification Products Co Ltd
SSE:603014

Watchlist Manager
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
Watchlist
Price: 41.56 CNY -0.65% Market Closed
Market Cap: 17.4B CNY

Operating Margin
Shandong Weigao Blood Purification Products Co Ltd

14.1%
Current
13%
Average
3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.1%
=
Operating Profit
508.9m
/
Revenue
3.6B

Operating Margin Across Competitors

No Stocks Found

Shandong Weigao Blood Purification Products Co Ltd
Glance View

Market Cap
17.4B CNY
Industry
Health Care

Shandong Weigao Blood Purification Products Co Ltd is a China-based company mainly engaged in the research and development, production, and sales of blood purification medical products. The Company's products mainly include hemodialysis products and peritoneal dialysis products. The hemodialysis products mainly include hemodialysis machines, hemodialysis tubing, and hemodialysis machines. The peritoneal dialysis products mainly include peritoneal dialysis fluid, and others. The Company's products are exported to multiple countries and regions such as Ecuador and Indonesia.

Intrinsic Value
35.6 CNY
Overvaluation 14%
Intrinsic Value
Price
S
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.1%
=
Operating Profit
508.9m
/
Revenue
3.6B
What is the Operating Margin of Shandong Weigao Blood Purification Products Co Ltd?

Based on Shandong Weigao Blood Purification Products Co Ltd's most recent financial statements, the company has Operating Margin of 14.1%.

Back to Top